echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Aging Cell: Why are APOE ε4 carriers at high risk of Alzheimer's disease?

    Aging Cell: Why are APOE ε4 carriers at high risk of Alzheimer's disease?

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Apolipoprotein E (APOE) is the strongest genetic risk factor for sporadic Alzheimer's disease (AD).


    Statistics show that 15%-25% of the population carry the APOE ε4 allele, and 2%-3% are homozygous.


    The product of the APOE gene is a lipoprotein, which binds to lipids and plays a role in cholesterol metabolism.


    cholesterol

    Recently, researchers have explored the effect of APOE ε4 genotype on the metabolism of platelets and lymphocytes in patients with Alzheimer's disease (AD).


    APOE ε4 carriers have lower average platelet mitochondrial cytochrome oxidase Vmax activity and significantly higher lymphocyte Annexin V (a marker of apoptosis).


    In APOE ε4 lymphocytes, the proteins that mediate mitosis and energy induction are higher.


    APOE ε4 lymphocytes have higher levels of AceCSI, ATP CL, and phosphorylated ACC.


    RNAseq MitoCarta3.


    RNAseq MitoCarta3.


    APOE ε4 allele activates the inflammatory pathway and modulates the bio-energetic signal APOE ε4 allele activates the inflammatory pathway and modulates the bio-energetic signal

    Neither medication nor brain histopathology can explain these findings.


     

    Original source:

    Original source:

    Heather M.


    et al.


     



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.